儿童非结核分枝杆菌病的研究进展

doi:10.19982/j.issn.1000-6621.20230243

摘要/Abstract

摘要：

全球儿童非结核分枝杆菌(non-tuberculous mycobacteria,NTM)感染率呈现上升趋势。儿童NTM病的临床表现与成人疾病存在明显差异,但其相关情况的报道总体偏少。本文总结了儿童NTM病的流行病学特点、常见疾病类型的致病菌种、主要临床表现及其诊断和治疗方案,以期帮助读者全面系统地了解儿童NTM病。

关键词: 儿童, 分枝杆菌,非典型性, 综述文献(主题)

Abstract:

The prevalence of non-tuberculous mycobacteria (NTM) disease in children is increasing globally. The clinical manifestations of NTM disease in children are significantly different from those in adults,although only a few related literatures have been published. This article summarizes the epidemiological characterization, the common disease type and the most pathogenic NTM species, main clinical manifestations, diagnosis and treatment of pediatric NTM diseases, so as to strength the understanding of the disease.

Key words: Child, Mycobacteria,atypical, Review literature as topic

中图分类号:

R378.91

蒋晓祎, 梁倩, 薛毅, 黄海荣. 儿童非结核分枝杆菌病的研究进展[J]. 中国防痨杂志, 2023, 45(11): 1103-1107. doi: 10.19982/j.issn.1000-6621.20230243

Jiang Xiaoyi, Liang Qian, Xue Yi, Huang Hairong. The progress of non-tuberculous mycobacterial disease in children[J]. Chinese Journal of Antituberculosis, 2023, 45(11): 1103-1107. doi: 10.19982/j.issn.1000-6621.20230243

参考文献 46

[1]	罗雪娇, 沙巍. 《非结核分枝杆菌病诊断》解读. 结核与肺部疾病杂志, 2021, 2(2): 116-119. doi:10.3969/j.issn.2096-8493.2021.02.005.
[2]	Blyth CC, Best EJ, Jones CA, et al. Nontuberculous mycobacterial infection in children: a prospective national study. Pediatr Infect Dis J, 2009, 28(9):801-805. doi:10.1097/INF.0b013e31819f7b3. pmid: 19636280
[3]	Pham-Huy A, Robinson JL, Tapiéro B, et al. Current trends in nontuberculous mycobacteria infections in Canadian children: A pediatric investigators collaborative network on infections in Canada (PICNIC) study. Paediatr Child Health, 2010, 15(5):276-282. doi:10.1093/pch/15.5.276.
[4]	Meoli A, Deolmi M, Iannarella R, et al. Non-Tuberculous Mycobacterial Diseases in Children. Pathogens, 2020, 9(7):553. doi:10.3390/pathogens9070553.
[5]	Reuss AM, Wiese-Posselt M, Weissmann B, et al. Incidence rate of nontuberculous mycobacterial disease in immunocompetent children: a prospective nationwide surveillance study in Germany. Pediatr Infect Dis J, 2009, 28(7):642-644. doi:10.1097/INF.0b013e3181978e8e. pmid: 19561429
[6]	Haverkamp MH, Arend SM, Lindeboom JA, et al. Nontuberculous mycobacterial infection in children: a 2-year prospective surveillance study in the Netherlands. Clin Infect Dis, 2004, 39(4):450-456. doi:10.1086/422319. pmid: 15356803
[7]	Tebruegge M, Pantazidou A, MacGregor D, et al. Nontuberculous Mycobacterial Disease in Children-Epidemiology, Diagnosis & Management at a Tertiary Center. PLoS One, 2016, 11(1):e0147513. doi:10.1371/journal.pone.0147513.
[8]	Varghese B, Enani M, Shoukri M, et al. Burden of non-tuberculous mycobacterial diseases in Saudi Arabian children: The first nationwide experience. J Infect Public Health, 2019, 12(6):803-808. doi:10.1016/j.jiph.2019.04.004.
[9]	郭倩, 申晨. 儿童非结核分枝杆菌病研究进展. 结核与肺部疾病杂志, 2021, 2 (2): 184-188. doi:10.3969/j.issn.2096-8493.2021.02.017.
[10]	Gelder CM, Hart KW, Williams OM, et al. Vitamin D receptor gene polymorphisms and susceptibility to Mycobacterium malmoense pulmonary disease. J Infect Dis, 2000, 181(6):2099-2102. doi:10.1086/315489. pmid: 10837203
[11]	Bouso JM, Burns JJ, Amin R, et al. Household proximity to water and nontuberculous mycobacteria in children with cystic fibrosis. Pediatr Pulmonol, 2017, 52(3):324-330. doi:10.1002/ppul.23646.
[12]	Thomson R, Tolson C, Carter R, et al. Isolation of nontuberculous mycobacteria (NTM) from household water and shower aerosols in patients with pulmonary disease caused by NTM. J Clin Microbiol, 2013, 51(9):3006-3011. doi:10.1128/JCM.00899-13. pmid: 23843489
[13]	Gallois Y, Cogo H, Debuisson C, et al. Nontuberculous lymphadenitis in children: What management strategy? Int J Pediatr Otorhinolaryngol, 2019, 122:196-202. doi:10.1016/j.ijporl.2019.04.012.
[14]	Park SG, Kim H, Paik JH, et al. Cluster of Lymphadenitis due to Nontuberculous Mycobacterium in Children and Adolescents 8-15 Years of Age. J Korean Med Sci, 2019, 34(46):e302. doi:10.3346/jkms.2019.34.e302.
[15]	Floto RA, Olivier KN, Saiman L, et al. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis. Thorax, 2016, 71 Suppl 1(Suppl 1):i1-i22. doi:10.1136/thoraxjnl-2015-207360.
[16]	Ford TJ, Silcock RA, Holland SM. Overview of nontuberculous mycobacterial disease in children. J Paediatr Child Health, 2021, 57(1):15-18. doi:10.1111/jpc.15257.
[17]	Haverkamp MH, van de Vosse E, van Dissel JT. Nontuberculous mycobacterial infections in children with inborn errors of the immune system. J Infect, 2014, 68 Suppl 1:S134-S150. doi:10.1016/j.jinf.2013.09.024.
[18]	López-Varela E, García-Basteiro AL, Santiago B, et al. Non-tuberculous mycobacteria in children: muddying the waters of tuberculosis diagnosis. Lancet Respir Med, 2015, 3(3):244-256. doi:10.1016/S2213-2600(15)00062-4. pmid: 25773213
[19]	Reilly AF, McGowan KL. Atypical mycobacterial infections in children with cancer. Pediatr Blood Cancer, 2004, 43(6):698-702. doi:10.1002/pbc.20061. pmid: 15390314
[20]	Loizos A, Soteriades ES, Pieridou D, et al. Lymphadenitis by non-tuberculous mycobacteria in children. Pediatr Int, 2018, 60(12):1062-1067. doi:10.1111/ped.13708. pmid: 30290041
[21]	Parkins MD, Floto RA. Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis. J Cyst Fibros, 2015, 14(3):293-304. doi:10.1016/j.jcf.2015.03.012. pmid: 25881770
[22]	Chirasuthat P, Triyangkulsri K, Rutnin S, et al. Cutaneous nontuberculous mycobacterial infection in Thailand: A 7-year retrospective review. Medicine (Baltimore), 2020, 99(10):e19355. doi:10.1097/MD.0000000000019355.
[23]	Bhattacharya J, Mohandas S, Goldman DL. Nontuberculous Mycobacterial Infections in Children. Pediatr Rev, 2019, 40(4):179-190. doi:10.1542/pir.2018-0131. pmid: 30936399
[24]	郑惠文, 申阿东. 儿童非结核分枝杆菌病的诊断和治疗进展. 中国防痨杂志, 2021, 43(9):979-982. doi:10.3969/j.issn.1000-6621.2021.09.021.
[25]	Zeharia A, Eidlitz-Markus T, Haimi-Cohen Y, et al. Management of nontuberculous mycobacteria-induced cervical lymphadenitis with observation alone. Pediatr Infect Dis J, 2008, 27(10):920-922. doi:10.1097/INF.0b013e3181734fa3. pmid: 18787500
[26]	Kuntz M, Kohlfürst DS, Feiterna-Sperling C, et al. Risk Factors for Complicated Lymphadenitis Caused by Nontuberculous Mycobacteria in Children. Emerg Infect Dis, 2020, 26(3):579-586. doi:10.3201/eid2603.191388. pmid: 32091372
[27]	肖媛媛, 伏利兵, 邢嬛, 等. 儿童皮肤非结核分枝杆菌感染1例. 中国皮肤性病学杂志, 2012, 26(9):109-111.
[28]	Franco-Paredes C, Marcos LA, Henao-Martínez AF, et al. Cutaneous Mycobacterial Infections. Clin Microbiol Rev, 2018, 32(1):e00069-18. doi:10.1128/CMR.00069-18.
[29]	Asiimwe BB, Bagyenzi GB, Ssengooba W, et al. Species and genotypic diversity of non-tuberculous mycobacteria isolated from children investigated for pulmonary tuberculosis in rural Uganda. BMC Infect Dis, 2013, 13:88. doi:10.1186/1471-2334-13-88. pmid: 23413873
[30]	Ahmed MI, Kulkarni H, Shajpal S, et al. Early detection of non-tuberculous mycobacteria in children with cystic fibrosis using induced sputum at annual review. Pediatr Pulmonol, 2019, 54(3):257-263. doi:10.1002/ppul.24220.
[31]	王熠, 陆静, 李苏梅, 等. 84例非结核分枝杆菌肺病患者临床特征及耐药性分析. 结核与肺部疾病杂志, 2021, 2(3): 223-227. doi:10.3969/j.issn.2096-8493.20210054.
[32]	Zimmermann P, Curtis N, Tebruegge M. Nontuberculous mycobacterial disease in childhood-update on diagnostic approaches and treatment. J Infect, 2017, 74 Suppl 1:S136-S142. doi:10.1016/S0163-4453(17)30204-9.
[33]	Wu UI, Holland SM. Host susceptibility to non-tuberculous mycobacterial infections. Lancet Infect Dis, 2015, 15(8):968-980. doi:10.1016/S1473-3099(15)00089-4.
[34]	Akpek G, Lee SM, Gagnon DR, et al. Bone marrow aspiration, biopsy, and culture in the evaluation of HIV-infected patients for invasive mycobacteria and histoplasma infections. Am J Hematol, 2001, 67(2):100-106. doi:10.1002/ajh.1086. pmid: 11343381
[35]	Al Yazidi LS, Marais BJ, Hazelton B, et al. Nontuberculous Mycobacteria in Children: A Focus on Bloodstream Infections. Pediatr Infect Dis J, 2017, 36(4):374-378. doi:10.1097/INF.0000000000001448. pmid: 27918379
[36]	中华医学会结核病学分会,《中华结核和呼吸杂志》编辑委员会. 非结核分枝杆菌病诊断与治疗专家共识. 中华结核和呼吸杂志, 2012, 35(8):572-580. doi:10.3760/cma.j.issn.1001-0939.2012.08.006.
[37]	廖鑫磊, 王桂荣. 非结核分枝杆菌病分子诊断技术概述. 结核与肺部疾病杂志, 2021, 2(2):98-101. doi:10.3969/j.issn.2096-8493.2021.02.002.
[38]	Wei W, Cao J, Wu XC, et al. Diagnostic performance of metagenomic next-generation sequencing in non-tuberculous mycobacterial pulmonary disease when applied to clinical practice. Infection, 2023, 51(2):397-405. doi:10.1007/s15010-022-01890-z.
[39]	Zimmermann P, Tebruegge M, Curtis N, et al. The management of non-tuberculous cervicofacial lymphadenitis in children: A systematic review and meta-analysis. J Infect, 2015, 71(1):9-18. doi:10.1016/j.jinf.2015.02.010. pmid: 25727993
[40]	Harris RL, Modayil P, Adam J, et al. Cervicofacial nontuberculous mycobacterium lymphadenitis in children: is surgery always necessary? Int J Pediatr Otorhinolaryngol, 2009, 73(9):1297-1301. doi:10.1016/j.ijporl.2009.06.006.
[41]	Elston D. Nontuberculous mycobacterial skin infections: recognition and management. Am J Clin Dermatol, 2009, 10(5):281-285. doi:10.2165/00128071-200910050-00001. pmid: 19658440
[42]	中华医学会结核病学分会. 非结核分枝杆菌病诊断与治疗指南(2020年版). 中华结核和呼吸杂志, 2020, 43(11):918-946. doi:10.3760/cma.j.cn112147-20200508-00570.
[43]	Hughes DA, Bokobza I, Carr SB. Eradication success for non-tuberculous mycobacteria in children with cystic fibrosis. Eur Respir J, 2021, 57(5):2003636. doi:10.1183/13993003.03636-2020.
[44]	Waters V, Ratjen F. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis. Cochrane Database Syst Rev, 2012, 12:CD010004. doi:10.1002/14651858.CD010004.pub2.
[45]	Karakousis PC, Moore RD, Chaisson RE. Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy. Lancet Infect Dis, 2004, 4(9):557-565. doi:10.1016/S1473-3099(04)01130-2. pmid: 15336223
[46]	Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med, 2007, 175(4):367-416. doi:10.1164/rccm.200604-571ST.